RnRMarketResearch.com adds “Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H1 2015” to its store. This report provides an overview of the Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)’s therapeutic pipeline.

Dallas, TX -- (SBWire) -- 06/23/2015 --The report "Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)" provides comprehensive information on the therapeutic development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) and special features on late-stage and discontinued projects.

Complete report on Progressive Supranuclear Palsy with 18 market data tables and 12 figures, spread across 35 pages is available at http://www.rnrmarketresearch.com/netherton-syndrome-trichorrhexis-invaginata-bamboo-hair-pipeline-review-h1-2015-market-report.html .

Companies discussed in this Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H1 2015 report include Med Discovery SA, Novartis AG, SATT Lutech SAS and Skinvisible Pharmaceuticals, Inc.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are BPR-277, Drug to Inhibit Serine Proteinase for Netherton Syndrome, MDPK-67b, Small Molecules to Inhibit Kallikrein for Netherton Syndrome and Synthetic Peptides to Inhibit Kallikrein for Immunology, Dermatological and Genetic Disorders.

Order a purchase copy of this report @
http://www.rnrmarketresearch.com/contacts/purchase?rname=392697
(This is a premium report priced at US$2000 for a single user License.)

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

List of Tables
Number of Products under Development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), H1 2015 7
Number of Products under Development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Comparative Analysis by Unknown Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline by Med Discovery SA, H1 2015 16
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline by Novartis AG, H1 2015 17
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline by SATT Lutech SAS, H1 2015 18
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline by Skinvisible Pharmaceuticals, Inc., H1 2015 19
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Stage and Target, H1 2015 22
Number of Products by Stage and Mechanism of Action, H1 2015 24
Number of Products by Stage and Route of Administration, H1 2015 25
Number of Products by Stage and Molecule Type, H1 2015 27

List of Figures
Number of Products under Development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), H1 2015 7
Number of Products under Development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 12
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Top 10 Targets, H1 2015 21
Number of Products by Stage and Top 10 Targets, H1 2015 22
Number of Products by Top 10 Mechanism of Actions, H1 2015 23
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 24
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 25
Number of Products by Top 10 Molecule Types, H1 2015 26
Number of Products by Stage and Top 10 Molecule Types, H1 2015 27

Explore more reports on Therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.